Meturedepa (AB 132) functions as a radiation sensitizer, enhancing the biological effects of radiation. When combined with suboptimal doses of X-ray radiation, this combined therapy achieves better outcomes in terms of tumor shrinkage compared to Meturedepa used alone. Meturedepa is applicable in the research of bronchogenic carcinoma[1].
Molecular Weight:
275.28
CAS Number:
[1661-29-6]
Formula:
C11H22N3O3P
Target:
DNA/RNA Synthesis
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
